Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11430) 11430
Publication (1601) 1601
Book Chapter (158) 158
Book Review (89) 89
Dissertation (43) 43
Conference Proceeding (38) 38
Book / eBook (12) 12
Magazine Article (10) 10
Trade Publication Article (3) 3
Data Set (2) 2
Paper (2) 2
Web Resource (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6765) 6765
index medicus (5564) 5564
female (3311) 3311
male (3186) 3186
tuberculosis (2997) 2997
adult (2585) 2585
infectious diseases (2196) 2196
infection (2014) 2014
middle aged (1996) 1996
latent tuberculosis (1948) 1948
immunology (1726) 1726
latent infection (1708) 1708
animals (1617) 1617
infections (1567) 1567
diagnosis (1418) 1418
health aspects (1365) 1365
virology (1359) 1359
microbiology (1343) 1343
latent tuberculosis - diagnosis (1200) 1200
adolescent (1194) 1194
latent tuberculosis infection (1163) 1163
aged (1103) 1103
risk factors (1089) 1089
analysis (1051) 1051
mycobacterium-tuberculosis (1007) 1007
research (975) 975
young adult (971) 971
hiv (935) 935
viruses (903) 903
tuberculin test (891) 891
respiratory system (850) 850
research article (828) 828
child (782) 782
medicine (772) 772
article (768) 768
prevalence (745) 745
epstein-barr virus (740) 740
mycobacterium tuberculosis (725) 725
mice (714) 714
disease (712) 712
expression (694) 694
tuberculosis - diagnosis (685) 685
risk (677) 677
epidemiology (646) 646
antitubercular agents - therapeutic use (641) 641
multidisciplinary sciences (622) 622
human immunodeficiency virus--hiv (611) 611
care and treatment (608) 608
proteins (606) 606
pulmonary tuberculosis (606) 606
latent tuberculosis - epidemiology (574) 574
gene expression (572) 572
mycobacterium tuberculosis - immunology (560) 560
antigens (554) 554
children (547) 547
skin-test (547) 547
lymphocytes (544) 544
virus diseases (544) 544
sensitivity and specificity (534) 534
epstein-barr-virus (516) 516
child, preschool (512) 512
public, environmental & occupational health (512) 512
latent tuberculosis - drug therapy (503) 503
biology (500) 500
oncology (498) 498
science (491) 491
herpesvirus 4, human - genetics (488) 488
latent (488) 488
public health (486) 486
tuberculosis - epidemiology (480) 480
gene-expression (479) 479
replication (479) 479
latent reservoir (475) 475
active tuberculosis (471) 471
dna (469) 469
studies (465) 465
activation (457) 457
tuberculin skin test (447) 447
nasopharyngeal carcinoma (446) 446
medical research (440) 440
cell biology (437) 437
retrospective studies (437) 437
bacterial infections and mycoses (428) 428
incidence (424) 424
polymerase chain reaction (423) 423
antiretroviral therapy (415) 415
cancer (415) 415
plant sciences (414) 414
t cells (412) 412
latency (410) 410
prevention (410) 410
latent tuberculosis - immunology (407) 407
therapy (406) 406
united-states (406) 406
hiv infections - drug therapy (404) 404
medicine, general & internal (403) 403
genetic aspects (402) 402
interferon (401) 401
cd4 t-cells (381) 381
infant (381) 381
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Robarts - Stacks (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Mathematical Sciences - Stacks (1) 1
OISE - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10902) 10902
Spanish (137) 137
French (130) 130
German (84) 84
Korean (71) 71
Japanese (65) 65
Portuguese (53) 53
Chinese (38) 38
Russian (36) 36
Polish (28) 28
Italian (21) 21
Turkish (14) 14
Czech (10) 10
Persian (9) 9
Croatian (6) 6
Hebrew (3) 3
Slovak (3) 3
Arabic (2) 2
Danish (2) 2
Dutch (2) 2
Hungarian (2) 2
Serbian (2) 2
Finnish (1) 1
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Latent Mycobacterium tuberculosis Infection
by Getahun, Haileyesus and Matteelli, Alberto and Chaisson, Richard E and Raviglione, Mario
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 22, pp. 2127 - 2135
About one third of the world population has latent M. tuberculosis infection. This review explains the approach to patients with latent infection, including an... 
UNITED-STATES | 12-DOSE REGIMEN | IMMUNE-RESPONSE | MEDICINE, GENERAL & INTERNAL | CLINICAL-TRIAL | IMMUNODEFICIENCY-VIRUS-INFECTION | INTRAVENOUS-DRUG-USERS | ANTIRETROVIRAL THERAPY | ISONIAZID PREVENTIVE THERAPY | GAMMA RELEASE ASSAYS | PROSPECTIVE COHORT | Rifampin - analogs & derivatives | Antitubercular Agents - adverse effects | Drug Administration Schedule | Humans | Risk Factors | Latent Tuberculosis - epidemiology | Latent Tuberculosis - diagnosis | Isoniazid - administration & dosage | Latent Tuberculosis - drug therapy | Mycobacterium tuberculosis | Antitubercular Agents - administration & dosage | Latent Tuberculosis - etiology | Rifampin - administration & dosage | Drug Therapy, Combination | Practice Guidelines as Topic | Usage | Care and treatment | Tuberculin test | Tuberculosis | Diagnosis | Risk factors | Cost-benefit analysis | Latent infection | Infections | Pathogenesis | Epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries
by Garcia-Doval, Ignacio, MD, PhD and Cohen, Arnon D., MD, PhD and Cazzaniga, Simone, PhD and Feldhamer, Ilan, PhD and Addis, Antonio, PharmD, PhD and Carretero, Gregorio, MD and Ferrándiz, Carlos, MD, PhD and Stern, Robert S., MD and Naldi, Luigi, MD, PhD and Psonet Network
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 76, Issue 2, pp. 299 - 308.e16
Background Anti–tumor necrosis factor (TNF) therapy in psoriasis has been associated with an increased risk of serious infections compared with nonbiologic... 
Dermatology | immunosuppressive agents | anti-inflammatory agents | anti–tumor necrosis factor | psoriasis/drug therapy | safety | biological agents | RHEUMATOID-ARTHRITIS | LATENT TUBERCULOSIS INFECTION | BIOLOGICS | DERMATOLOGY | SYSTEMIC TREATMENT | DISEASE | anti-tumor necrosis factor | ADVERSE EVENTS | Granuloma - microbiology | Severity of Illness Index | Skin Diseases, Bacterial - chemically induced | Prospective Studies | Psoriasis - drug therapy | Risk Assessment | Humans | Infection - chemically induced | Infection - epidemiology | Skin Diseases, Bacterial - epidemiology | Registries | Granuloma - chemically induced | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Medical colleges | Care and treatment | Bacterial infections | Psoriasis | Family medicine | Dermatologic agents | Epidemiology | Risk factors | Necrosis | Tumor necrosis factor | Formulae, receipts, prescriptions | Health aspects | Tumors | Retinoids | Immunosuppressive agents | Methotrexate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Infection
by Tsuyuguchi, Kazunari
Japanese Journal of Chest Diseases, ISSN 0385-3667, 2015, Volume 74, pp. S28 - S31
Infection and disease | Mycobacterium tuberculosis | Airborne infection | Droplet nuclei infection | Interferon gamma release assay (IGRA) | Latent tuberculosis infection (LTBI)
Journal Article
Details down arrow
4. Full Text Microvesicles and Viral Infection
by David G. Meckes Jr and Nancy Raab-Traub
Journal of Virology, ISSN 0022-538X, 12/2011, Volume 85, Issue 24, pp. 12844 - 12854
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
SIMPLEX-VIRUS TYPE-1 | HEPATITIS-B-VIRUS | VIROLOGY | MULTIVESICULAR BODIES | EXTRACELLULAR VESICLES | STRUCTURES L-PARTICLES | APOPTOTIC BODIES | CELL-DERIVED EXOSOMES | NASOPHARYNGEAL CARCINOMA-CELLS | LATENT MEMBRANE PROTEIN-1 | HUMAN T-CELLS | Exosomes - metabolism | Viruses - pathogenicity | Models, Biological | Humans | Viruses - growth & development | Exosomes - ultrastructure | Viruses - ultrastructure | Minireview
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Treatment of latent tuberculosis infection a network meta-analysis
by Stagg, Helen R and Zenner, Dominik and Harris, Ross J and Muñoz, Laura and Lipman, Marc C and Abubakar, Ibrahim
Annals of Internal Medicine, ISSN 0003-4819, 09/2014, Volume 161, Issue 6, pp. 419 - 428
Background: Effective treatment of latent tuberculosis infection (LTBI) is an important component of TB elimination programs. Promising new regimens that may... 
PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | HIV-INFECTION | CHEMOPROPHYLAXIS REGIMENS | DOUBLE-BLIND | ADULTS | RIFAMPIN | PYRAZINAMIDE | RANDOMIZED CONTROLLED-TRIAL | ISONIAZID PREVENTIVE THERAPY | CHILDREN | Rifampin - analogs & derivatives | Antitubercular Agents - adverse effects | Pyrazinamide - adverse effects | Drug Administration Schedule | Humans | Isoniazid - adverse effects | Pyrazinamide - therapeutic use | Rifampin - adverse effects | Latent Tuberculosis - drug therapy | Isoniazid - therapeutic use | Rifampin - therapeutic use | Drug Therapy, Combination | Chemical and Drug Induced Liver Injury - etiology | Antitubercular Agents - therapeutic use | Care and treatment | Tuberculosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
by Houben, Rein M. G. J and Dodd, Peter J
PLoS Medicine, ISSN 1549-1277, 10/2016, Volume 13, Issue 10, p. e1002152
Background The existing estimate of the global burden of latent TB infection (LTBI) as "one-third" of the world population is nearly 20 y old. Given the... 
MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | COUNTRIES | ACTIVE TUBERCULOSIS | REACTIVATION | REINFECTION | RISK | PREVALENCE | RELEASE ASSAYS | TRENDS | Isoniazid - pharmacology | Prevalence | Global Health | Humans | Antitubercular Agents - pharmacology | Latent Tuberculosis - epidemiology | Risk | Mycobacterium tuberculosis - drug effects | Tuberculosis, Multidrug-Resistant - epidemiology | Incidence | Tuberculosis, Multidrug-Resistant - microbiology | Mycobacterium tuberculosis - physiology | Latent Tuberculosis - microbiology | Epidemics | Usage | Tuberculosis | Distribution | United Kingdom | Mathematical models | Models | Research | Risk factors | Studies | Infectious diseases | Demography | Research & development--R&D | Population | Infections | Medical diagnosis | Estimates | Hygiene | Research & development | R&D
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Treatment of latent tuberculosis infection: An updated network meta-analysis
by Zenner, Dominik and Beer, Netta and Harris, Ross J and Lipman, Marc C and Stagg, Helen R and Van Der Werf, Marieke J
Annals of Internal Medicine, ISSN 0003-4819, 08/2017, Volume 167, Issue 4, pp. 248 - 255
Background: Treatment of latent tuberculosis infection (LTBI) is an important component of tuberculosis (TB) control, and this study updates a previous network... 
MEDICINE, GENERAL & INTERNAL | EFFICACY | DOUBLE-BLIND | ADULTS | ANTIRETROVIRAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | RIFAPENTINE | ISONIAZID PREVENTIVE THERAPY | REGIMENS | CHILDREN | Antitubercular Agents - adverse effects | Pyrazinamide - adverse effects | Humans | Isoniazid - adverse effects | Pyrazinamide - therapeutic use | Rifampin - adverse effects | Latent Tuberculosis - drug therapy | Adult | Isoniazid - therapeutic use | Rifampin - therapeutic use | Network Meta-Analysis | Child | Chemical and Drug Induced Liver Injury - etiology | Drug Combinations | Antitubercular Agents - therapeutic use | Care and treatment | Usage | Dosage and administration | Tuberculosis | Rifampin | Meta-analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of HIV-1 Infection on T-Cell-based and Skin Test Detection of Tuberculosis Infection
by Rangaka, Molebogeng Xheeda and Wilkinson, Katalin A and Seldon, Ronnett and Van Cutsem, Gilles and Meintjes, Graeme Ayton and Morroni, Chelsea and Mouton, Priscilla and Diwakar, Lavanya and Connell, Tom G and Maartens, Gary and Wilkinson, Robert J
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2007, Volume 175, Issue 5, pp. 514 - 520
Rationale: Two forms of the IFN-gamma release assay (IFNGRA) to detect tuberculosis infection are available, but neither has been evaluated in comparable... 
Antigens | Diagnostic techniques and procedures | Interferons | CFP-10 protein | ESAT-6 protein | MYCOBACTERIUM-TUBERCULOSIS | DIAGNOSIS | GOLD | LATENT TUBERCULOSIS | INTERFERON-GAMMA ASSAY | ENUMERATION | antigens | diagnostic techniques and procedures | WHOLE-BLOOD | interferons | RESPIRATORY SYSTEM | ANERGY | RAPID DETECTION | CRITICAL CARE MEDICINE | Diagnosis, Differential | Reproducibility of Results | Cross-Sectional Studies | Follow-Up Studies | HIV Infections - virology | Humans | Male | CD4 Lymphocyte Count | Urban Population | Tuberculin Test | Tuberculosis, Pulmonary - complications | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV-1 - immunology | Tuberculosis, Pulmonary - immunology | HIV Antigens - immunology | Tuberculosis, Pulmonary - diagnosis | HIV Infections - complications | Adult | Female
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
by Shan, Liang and Deng, Kai and Gao, Hongbo and Xing, Sifei and Capoferri, Adam A and Durand, Christine M and Rabi, S. Alireza and Laird, Gregory M and Kim, Michelle and Hosmane, Nina N and Yang, Hung-Chih and Zhang, Hao and Margolick, Joseph B and Li, Linghua and Cai, Weiping and Ke, Ruian and Flavell, Richard A and Siliciano, Janet D and Siliciano, Robert F
Immunity, ISSN 1074-7613, 10/2017, Volume 47, Issue 4, pp. 766 - 775.e3
The latent reservoir for HIV-1 in resting memory CD4 T cells is the major barrier to curing HIV-1 infection. Studies of HIV-1 latency have focused on... 
ACTIVATION | REPLICATION | PERSISTENCE | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | IMMUNODEFICIENCY-VIRUS TYPE-1 | IMMUNOLOGY | NF-KAPPA-B | EXPRESSION | VIRAL RESERVOIR | LYMPHOCYTES | Humans | Male | Host-Pathogen Interactions - immunology | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - genetics | Lymphocyte Activation - immunology | Flow Cytometry | HIV-1 - physiology | Female | Transcription, Genetic | CD4-Positive T-Lymphocytes - virology | Cellular Reprogramming - genetics | Cytokines - genetics | Immunologic Memory - genetics | Immunologic Memory - immunology | Cytokines - immunology | T-Lymphocytes, Cytotoxic - immunology | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Gene Expression Profiling - methods | Virus Replication - immunology | Reverse Transcriptase Polymerase Chain Reaction | Cellular Reprogramming - immunology | HIV-1 - immunology | T-Lymphocytes, Cytotoxic - metabolism | Virus Latency - immunology | Immunological memory | CCR5 protein | Memory cells | Transcription | CD8 antigen | Memory | Latent infection | Effector cells | Viruses | Infections | Lymphocytes T | Vaccines | Kinases | Gene expression | CD4 antigen | Latency | Lymphocytes | Human immunodeficiency virus--HIV | Life cycle engineering | Chemokines | Life cycles
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Mycobacterium tuberculosis‐specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease
by Rozot, Virginie and Vigano, Selena and Mazza‐Stalder, Jesica and Idrizi, Elita and Day, Cheryl L and Perreau, Matthieu and Lazor‐Blanchet, Catherine and Petruccioli, Elisa and Hanekom, Willem and Goletti, Delia and Bart, Pierre‐Alexandre and Nicod, Laurent and Pantaleo, Giuseppe and Harari, Alexandre
European Journal of Immunology, ISSN 0014-2980, 06/2013, Volume 43, Issue 6, pp. 1568 - 1577
Protective immunity to Mycobacterium tuberculosis (Mtb) remains poorly understood and the role of Mtb‐specific CD8+ T cells is controversial. Here we performed... 
Functional profile | Cytotoxicity | Latent Mtb infection | Mtb‐specific CD8+ T cells | Active TB disease | T cells | Mtb-specific CD8 | MICE DEFICIENT | IMMUNOLOGY | GRANULYSIN | INTERFERON-GAMMA | PATHWAY | IMMUNE-RESPONSES | REACTIVATION | Mtb-specific CD8(+) T cells | PULMONARY TUBERCULOSIS | RESISTANCE | ANTIMICROBIAL ACTIVITY | ANTIGEN | T-Lymphocyte Subsets - immunology | Acute Disease | Cell Proliferation | Cytokines - metabolism | Humans | Cells, Cultured | Mycobacterium tuberculosis - immunology | Programmed Cell Death 1 Receptor - metabolism | Immunophenotyping | Latent Tuberculosis - immunology | Signaling Lymphocytic Activation Molecule Family | GPI-Linked Proteins - metabolism | Antigens, CD - metabolism | Tuberculosis, Pulmonary - immunology | CD8-Positive T-Lymphocytes - immunology | Receptors, Immunologic - metabolism | Health aspects | Tuberculosis | T cell receptors | Immunology | Lymphocytes | Mtb-specific CD8+ T cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?
by Denkinger, C.M and Dheda, K and Pai, M
Clinical Microbiology and Infection, ISSN 1198-743X, 06/2011, Volume 17, Issue 6, pp. 806 - 814
Identification of latent tuberculosis (TB) infection and preventive therapy is important for TB control, especially in high-risk populations. Since the advent... 
guidelines | interferon-γ release assays | Diagnosis | immunodiagnostics | tuberculosis | interferon‐γ release assays | Immunodiagnostics | Tuberculosis | Interferon-γ release assays | Guidelines | MYCOBACTERIUM-TUBERCULOSIS | UNITED-STATES | TESTS | INFECTIOUS DISEASES | MANAGEMENT | QUALITY | LATENT TUBERCULOSIS | PREVENTION | MICROBIOLOGY | RECOMMENDATIONS | interferon-gamma release assays | Immunoassay - methods | Interferons - secretion | Clinical Laboratory Techniques - methods | Guidelines as Topic | Tuberculosis - diagnosis | Humans | Infection | Risk groups | Discordance | gamma -Interferon | Tuberculin | Skin tests
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement
by Bibbins-Domingo, Kirsten and Grossman, David C and Curry, Susan J and Bauman, Linda and Davidson, Karina W and Epling, John W and García, Francisco A.R and Herzstein, Jessica and Kemper, Alex R and Krist, Alex H and Kurth, Ann E and Landefeld, C. Seth and Mangione, Carol M and Phillips, William R and Phipps, Maureen G and Pignone, Michael P and US Preventive Serv Task Force and US Preventive Services Task Force
JAMA, ISSN 0098-7484, 09/2016, Volume 316, Issue 9, pp. 962 - 969
IMPORTANCE: Tuberculosis remains an important preventable disease in the United States. An effective strategy for reducing the transmission, morbidity, and... 
RIFAMPIN | MEDICINE, GENERAL & INTERNAL | Mass Screening | Tuberculosis | Risk Assessment | Humans | Adult | Primary Health Care | Advisory Committees | Latent Tuberculosis | Adults | Medical screening | Medical treatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights